If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Form 8.3 - DX LN

4 Jan 2024 15:30

RNS Number : 6755Y
Syquant Capital
04 January 2024

Table

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

DX Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

January 3, 2024

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

11,303,000

1.86%

(2) Derivatives (other than options):

47,000

0.00%

(3) Options and agreements to purchase/sell:

TOTAL:

11,350,000

1.87%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

1p ordinary

Purchase

994,049

47 GBp

(b) Derivatives transactions (other than options)

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

increasing a long position

5,951

47 GBp

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercising

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

N/A

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

N/A

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

January 4, 2024

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETUSVRRSBUARAR
Date   Source Headline
6th Feb 20194:40 pmRNSSecond Price Monitoring Extn
6th Feb 20194:35 pmRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSTrading Statement
17th Dec 20183:06 pmRNSDirector/PDMR Shareholding
4th Dec 201812:29 pmRNSResult of AGM
4th Dec 20187:00 amRNSAGM Statement
3rd Dec 20187:00 amRNSDirector Disclosure
7th Nov 201811:07 amRNSDirector Declaration
29th Oct 20184:35 pmRNSPrice Monitoring Extension
15th Oct 20187:00 amRNSNotice of AGM
2nd Oct 20183:47 pmRNSPreliminary Results - replacement
2nd Oct 20187:00 amRNSPreliminary Results
14th Aug 20184:40 pmRNSSecond Price Monitoring Extn
14th Aug 20184:35 pmRNSPrice Monitoring Extension
26th Jul 20187:00 amRNSGrant of share awards and PDMR notification
18th Jul 20187:00 amRNSTrading Update
14th Jun 20187:00 amRNSDirector/PDMR Shareholding
6th Jun 20183:02 pmRNSHolding(s) in Company
25th May 201810:50 amRNSGrant of Share Awards and PDMR Shareholding
24th May 20185:47 pmRNSHolding(s) in Company
23rd May 20188:45 amRNSCompletion of Transaction and Director Dealing
23rd May 20187:00 amRNSDirector/PDMR Shareholding
22nd May 20185:04 pmRNSTotal Voting Rights
22nd May 201811:38 amRNSResult of General Meeting
3rd May 20186:32 pmRNSFundraising and Loan Note Cancellation
29th Mar 20187:00 amRNSInterim Results
21st Mar 20187:00 amRNSAppointment of Chief Financial Officer
19th Mar 20187:00 amRNSNotice of Results
5th Feb 20183:29 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSChange of Adviser
3rd Jan 20185:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20171:19 pmRNSCompletion of Loan Note issue
22nd Dec 20171:14 pmRNSDirector/PDMR Shareholding
22nd Dec 20171:13 pmRNSGrant of share awards and PDMR notification
18th Dec 201711:09 amRNSHolding(s) in Company
15th Dec 201711:41 amRNSResult of GM
8th Dec 201712:22 pmRNSResult of AGM
28th Nov 20177:00 amRNSRe: GM Notice, Circular and Incentive Awards
14th Nov 20179:00 amRNSPosting of Annual Report & Notice of AGM
27th Oct 201712:07 pmRNSSecond Price Monitoring Extn
27th Oct 201712:02 pmRNSPrice Monitoring Extension
20th Oct 201712:07 pmRNSSecond Price Monitoring Extn
20th Oct 201712:02 pmRNSPrice Monitoring Extension
20th Oct 20177:00 amRNSBoard Changes
20th Oct 20177:00 amRNSPreliminary Results
9th Oct 20177:00 amRNS£24m Fundraising, CEO Appointment & Board Changes
29th Sep 201712:21 pmRNSRe: Property Transaction
28th Sep 20177:00 amRNSMajor New Contract with IKEA
22nd Sep 20177:00 amRNSFinancing Update, Property Disposal, Gatemore Loan
20th Sep 20174:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.